These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Telomere length in normal and neoplastic canine tissues. Cadile CD; Kitchell BE; Newman RG; Biller BJ; Hetler ER Am J Vet Res; 2007 Dec; 68(12):1386-91. PubMed ID: 18052745 [TBL] [Abstract][Full Text] [Related]
9. Telomeres and telomerase in sarcomas. Matsuo T; Shimose S; Kubo T; Fujimori J; Yasunaga Y; Ochi M Anticancer Res; 2009 Oct; 29(10):3833-6. PubMed ID: 19846916 [TBL] [Abstract][Full Text] [Related]
10. Curative-intent radiation therapy as a treatment modality for appendicular and axial osteosarcoma: a preliminary retrospective evaluation of 14 dogs with the disease. Walter CU; Dernell WS; LaRue SM; Lana SE; Lafferty MH; LaDue TA; Withrow SJ Vet Comp Oncol; 2005 Mar; 3(1):1-7. PubMed ID: 19379208 [TBL] [Abstract][Full Text] [Related]
11. Genomic instability and telomere fusion of canine osteosarcoma cells. Maeda J; Yurkon CR; Fujisawa H; Kaneko M; Genet SC; Roybal EJ; Rota GW; Saffer ER; Rose BJ; Hanneman WH; Thamm DH; Kato TA PLoS One; 2012; 7(8):e43355. PubMed ID: 22916246 [TBL] [Abstract][Full Text] [Related]
12. A novel small molecule Met inhibitor, PF2362376, exhibits biological activity against osteosarcoma. Liao AT; McCleese J; Kamerling S; Christensen J; London CA Vet Comp Oncol; 2007 Sep; 5(3):177-96. PubMed ID: 19754789 [TBL] [Abstract][Full Text] [Related]
13. Telomerase activity in head and neck cancer. Kunická Z; Mucha I; Fajkus J Anticancer Res; 2008; 28(5B):3125-9. PubMed ID: 19031968 [TBL] [Abstract][Full Text] [Related]
14. Survival analysis of one versus two treatments of local delivery cisplatin in a biodegradable polymer for canine osteosarcoma. Mehl ML; Seguin B; Dernell WS; Lafferty M; Kass PH; Withrow SJ Vet Comp Oncol; 2005 Jun; 3(2):81-6. PubMed ID: 19379216 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of telomerase-targeted therapies in canine cancer cell lines. Argyle DJ; McKevitt T; Gault E; Nasir L Vet Comp Oncol; 2004 Dec; 2(4):214-21. PubMed ID: 19379295 [TBL] [Abstract][Full Text] [Related]
16. Prevalence and potentially prognostic value of C-circles associated with alternative lengthening of telomeres in canine appendicular osteosarcoma. Bicanova L; Kreilmeier-Berger T; Reifinger M; Holzmann K; Kleiter M Vet Comp Oncol; 2021 Jun; 19(2):222-231. PubMed ID: 33211388 [TBL] [Abstract][Full Text] [Related]
17. Development of a new canine osteosarcoma cell line. Séguin B; Zwerdling T; McCallan JL; DeCock HE; Dewe LL; Naydan DK; Young AE; Bannasch DL; Foreman O; Kent MS Vet Comp Oncol; 2006 Dec; 4(4):232-40. PubMed ID: 19754807 [TBL] [Abstract][Full Text] [Related]
18. Nonradioactive detection of telomerase activity using the telomeric repeat amplification protocol. Herbert BS; Hochreiter AE; Wright WE; Shay JW Nat Protoc; 2006; 1(3):1583-90. PubMed ID: 17406450 [TBL] [Abstract][Full Text] [Related]
19. Telomerase activation in neoplastic cell immortalization and tumour progression. Looi LM; Ng MH; Cheah PL Malays J Pathol; 2007 Jun; 29(1):33-5. PubMed ID: 19105326 [TBL] [Abstract][Full Text] [Related]
20. Short telomeres resulting from heritable mutations in the telomerase reverse transcriptase gene predispose for a variety of malignancies. Hills M; Lansdorp PM Ann N Y Acad Sci; 2009 Sep; 1176():178-90. PubMed ID: 19796246 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]